Overview
Kazuhiro Kitajima-Kita practices in Japan. Mr. Kitajima-Kita is rated as an Advanced expert by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Mesothelioma, Prostate Cancer, Bone Tumor, Prostatectomy, and Tissue Biopsy.
His clinical research consists of co-authoring 215 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 32 articles in the study of Prostate Cancer.
Locations
Kawasaki, Japan
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MesotheliomaMr. Kitajima-Kita isDistinguished. Learn about Mesothelioma.
- Advanced
- Bone TumorMr. Kitajima-Kita isAdvanced. Learn about Bone Tumor.
- Breast CancerMr. Kitajima-Kita isAdvanced. Learn about Breast Cancer.
- Prostate CancerMr. Kitajima-Kita isAdvanced. Learn about Prostate Cancer.
- Experienced
- Acute Interstitial PneumoniaMr. Kitajima-Kita isExperienced. Learn about Acute Interstitial Pneumonia.
- Adult Soft Tissue SarcomaMr. Kitajima-Kita isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisMr. Kitajima-Kita isExperienced. Learn about Agranulocytosis.
- AngiosarcomaMr. Kitajima-Kita isExperienced. Learn about Angiosarcoma.
- Ataxia-TelangiectasiaMr. Kitajima-Kita isExperienced. Learn about Ataxia-Telangiectasia.
- B-Cell LymphomaMr. Kitajima-Kita isExperienced. Learn about B-Cell Lymphoma.